Related references
Note: Only part of the references are listed.Engineering light-controllable CAR T cells for cancer immunotherapy
Ziliang Huang et al.
SCIENCE ADVANCES (2020)
NR4A transcription factors limit CAR T cell function in solid tumours
Joyce Chen et al.
NATURE (2019)
An AND-Gated Drug and Photoactivatable Cre-loxP System for Spatiotemporal Control in Cell-Based Therapeutics
Molly E. Allen et al.
ACS SYNTHETIC BIOLOGY (2019)
Near-Infrared-Light Activatable Nanoparticles for Deep-Tissue-Penetrating Wireless Optogenetics
Nuo Yu et al.
ADVANCED HEALTHCARE MATERIALS (2019)
CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
Theodoros Giavridis et al.
NATURE MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Mechanogenetics for the remote and noninvasive control of cancer immunotherapy
Yijia Pan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Optogenetic Immunomodulation: Shedding Light on Antitumor Immunity
Peng Tan et al.
TRENDS IN BIOTECHNOLOGY (2017)
Tuning the Binding Affinities and Reversion Kinetics of a Light Inducible Dimer Allows Control of Transmembrane Protein Localization
Seth P. Zimmerman et al.
BIOCHEMISTRY (2016)
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
Hanren Dai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
Hanren Dai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
Remote control of therapeutic T cells through a small molecule-gated chimeric receptor
Chia-Yung Wu et al.
SCIENCE (2015)
Near-infrared photoactivatable control of Ca2+ signaling and optogenetic immunomodulation
Lian He et al.
ELIFE (2015)
Lutetium doping for making big core and core-shell upconversion nanoparticles
K. Huang et al.
JOURNAL OF MATERIALS CHEMISTRY C (2015)
Engineering an improved light-induced dimer (iLID) for controlling the localization and activity of signaling proteins
Gurkan Guntas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting of Antigens to B Lymphocytes via CD19 as a Means for Tumor Vaccine Development
Yunfeng Ma et al.
JOURNAL OF IMMUNOLOGY (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain et al.
CANCER DISCOVERY (2013)
Antigen-specific T-cell activation independently of the MHC: chimeric antigen receptor-redirected T cells
Markus Chmielewski et al.
FRONTIERS IN IMMUNOLOGY (2013)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
Rapid blue-light-mediated induction of protein interactions in living cells
Matthew J. Kennedy et al.
NATURE METHODS (2010)
Light-Emitting Diodes (LEDs) in Dermatology
Daniel Barolet
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2008)
Share Paper
